These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10256911)

  • 1. Pharmacists' and physicians' responses to the South Carolina Product Selection Act of 1978.
    Sumner ED; Karig AW; Hunt HH
    Contemp Pharm Pract; 1982; 5(2):124-9. PubMed ID: 10256911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists.
    Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM
    Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon].
    Blatt A; Chambon R; Lemardeley P
    Med Trop (Mars); 1997; 57(1):37-40. PubMed ID: 9289607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refilling prescriptions and physician consent.
    Bobrt KF; Purohit AA
    Contemp Pharm Pract; 1982; 5(2):80-4. PubMed ID: 10256914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic substitution practices in short-term hospitals.
    Doering PL; Klapp DL; McCormick WC; Russell WL
    Am J Hosp Pharm; 1982 Jun; 39(6):1028-32. PubMed ID: 7102686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do pharmacists' opinions affect their decision to dispense or recommend a visit to a doctor?
    Caamaño-Isorna F; Montes A; Takkouche B; Gestal-Otero JJ
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):659-64. PubMed ID: 15830396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generic drugs in morocco: survey of physicians].
    Zaoui S; Hakkou F; Filali H
    Therapie; 2011; 66(6):499-506. PubMed ID: 22186075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' attitudes toward PAs. Results of a Wisconsin study.
    Huntington S; Warnick JS
    Physician Assist; 1987 Sep; 11(9):108, 110-1, 114. PubMed ID: 10314648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical ideology and product confidence: future pharmacists' attitudes toward generic drug substitution.
    Pelton LE; Smith MC
    Health Mark Q; 1991; 8(3-4):181-92. PubMed ID: 10111968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' attitudes toward generic drug substitution by pharmacists.
    Brust M; Hawkins CF; Grayson D
    Tex Med; 1990 Mar; 86(3):45-9. PubMed ID: 2333636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
    Bongiorno RA; Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription prices under the New York generic substitution law.
    Francetić I; Lasagna L; Weintraub M; Karch FE
    Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaco-legal considerations in the clinical use of decongestants.
    Brushwood DB
    Pharmacotherapy; 1993; 13(6 Pt 2):135S-142S; discussion 143S-146S. PubMed ID: 7507591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.